Dysregulation of Translation Factors EIF2S1, EIF5A and EIF6 in Intestinal-Type Adenocarcinoma (ITAC)

Intestinal-type adenocarcinoma (ITAC) is a rare cancer of the nasal cavity and paranasal sinuses that occurs sporadically or secondary to exposure to occupational hazards, such as wood dust and leather. Eukaryotic translation initiation factors have been described as promising targets for novel canc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Christoph Schatz, Susanne Sprung, Volker Schartinger, Helena Codina-Martínez, Matt Lechner, Mario Hermsen, Johannes Haybaeck
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/1ff0ba05d48d4fcf9a956d515273c8dd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1ff0ba05d48d4fcf9a956d515273c8dd
record_format dspace
spelling oai:doaj.org-article:1ff0ba05d48d4fcf9a956d515273c8dd2021-11-25T17:02:09ZDysregulation of Translation Factors EIF2S1, EIF5A and EIF6 in Intestinal-Type Adenocarcinoma (ITAC)10.3390/cancers132256492072-6694https://doaj.org/article/1ff0ba05d48d4fcf9a956d515273c8dd2021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5649https://doaj.org/toc/2072-6694Intestinal-type adenocarcinoma (ITAC) is a rare cancer of the nasal cavity and paranasal sinuses that occurs sporadically or secondary to exposure to occupational hazards, such as wood dust and leather. Eukaryotic translation initiation factors have been described as promising targets for novel cancer treatments in many cancers, but hardly anything is known about these factors in ITAC. Here we performed in silico analyses, evaluated the protein levels of EIF2S1, EIF5A and EIF6 in tumour samples and non-neoplastic tissue controls obtained from 145 patients, and correlated these results with clinical outcome data, including tumour site, stage, adjuvant radiotherapy and survival. In silico analyses revealed significant upregulation of the translation factors EIF6 (ITGB4BP), EIF5, EIF2S1 and EIF2S2 (<i>p</i> < 0.05) with a higher arithmetic mean expression in ITAC compared to non-neoplastic tissue (NNT). Immunohistochemical analyses using antibodies against EIF2S1 and EIF6 confirmed a significantly different expression at the protein level (<i>p</i> < 0.05). In conclusion, this work identifies the eukaryotic translation initiation factors EIF2S1 and EIF6 to be significantly upregulated in ITAC. As these factors have been described as promising therapeutic targets in other cancers, this work identifies candidate therapeutic targets in this rare but often deadly cancer.Christoph SchatzSusanne SprungVolker SchartingerHelena Codina-MartínezMatt LechnerMario HermsenJohannes HaybaeckMDPI AGarticlesinonasal adenocarcinoma of the intestinal type (ITAC)translation factorsbiomarkersNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5649, p 5649 (2021)
institution DOAJ
collection DOAJ
language EN
topic sinonasal adenocarcinoma of the intestinal type (ITAC)
translation factors
biomarkers
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle sinonasal adenocarcinoma of the intestinal type (ITAC)
translation factors
biomarkers
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Christoph Schatz
Susanne Sprung
Volker Schartinger
Helena Codina-Martínez
Matt Lechner
Mario Hermsen
Johannes Haybaeck
Dysregulation of Translation Factors EIF2S1, EIF5A and EIF6 in Intestinal-Type Adenocarcinoma (ITAC)
description Intestinal-type adenocarcinoma (ITAC) is a rare cancer of the nasal cavity and paranasal sinuses that occurs sporadically or secondary to exposure to occupational hazards, such as wood dust and leather. Eukaryotic translation initiation factors have been described as promising targets for novel cancer treatments in many cancers, but hardly anything is known about these factors in ITAC. Here we performed in silico analyses, evaluated the protein levels of EIF2S1, EIF5A and EIF6 in tumour samples and non-neoplastic tissue controls obtained from 145 patients, and correlated these results with clinical outcome data, including tumour site, stage, adjuvant radiotherapy and survival. In silico analyses revealed significant upregulation of the translation factors EIF6 (ITGB4BP), EIF5, EIF2S1 and EIF2S2 (<i>p</i> < 0.05) with a higher arithmetic mean expression in ITAC compared to non-neoplastic tissue (NNT). Immunohistochemical analyses using antibodies against EIF2S1 and EIF6 confirmed a significantly different expression at the protein level (<i>p</i> < 0.05). In conclusion, this work identifies the eukaryotic translation initiation factors EIF2S1 and EIF6 to be significantly upregulated in ITAC. As these factors have been described as promising therapeutic targets in other cancers, this work identifies candidate therapeutic targets in this rare but often deadly cancer.
format article
author Christoph Schatz
Susanne Sprung
Volker Schartinger
Helena Codina-Martínez
Matt Lechner
Mario Hermsen
Johannes Haybaeck
author_facet Christoph Schatz
Susanne Sprung
Volker Schartinger
Helena Codina-Martínez
Matt Lechner
Mario Hermsen
Johannes Haybaeck
author_sort Christoph Schatz
title Dysregulation of Translation Factors EIF2S1, EIF5A and EIF6 in Intestinal-Type Adenocarcinoma (ITAC)
title_short Dysregulation of Translation Factors EIF2S1, EIF5A and EIF6 in Intestinal-Type Adenocarcinoma (ITAC)
title_full Dysregulation of Translation Factors EIF2S1, EIF5A and EIF6 in Intestinal-Type Adenocarcinoma (ITAC)
title_fullStr Dysregulation of Translation Factors EIF2S1, EIF5A and EIF6 in Intestinal-Type Adenocarcinoma (ITAC)
title_full_unstemmed Dysregulation of Translation Factors EIF2S1, EIF5A and EIF6 in Intestinal-Type Adenocarcinoma (ITAC)
title_sort dysregulation of translation factors eif2s1, eif5a and eif6 in intestinal-type adenocarcinoma (itac)
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/1ff0ba05d48d4fcf9a956d515273c8dd
work_keys_str_mv AT christophschatz dysregulationoftranslationfactorseif2s1eif5aandeif6inintestinaltypeadenocarcinomaitac
AT susannesprung dysregulationoftranslationfactorseif2s1eif5aandeif6inintestinaltypeadenocarcinomaitac
AT volkerschartinger dysregulationoftranslationfactorseif2s1eif5aandeif6inintestinaltypeadenocarcinomaitac
AT helenacodinamartinez dysregulationoftranslationfactorseif2s1eif5aandeif6inintestinaltypeadenocarcinomaitac
AT mattlechner dysregulationoftranslationfactorseif2s1eif5aandeif6inintestinaltypeadenocarcinomaitac
AT mariohermsen dysregulationoftranslationfactorseif2s1eif5aandeif6inintestinaltypeadenocarcinomaitac
AT johanneshaybaeck dysregulationoftranslationfactorseif2s1eif5aandeif6inintestinaltypeadenocarcinomaitac
_version_ 1718412763795030016